SG11201500346QA - Low-volume coagulation assay - Google Patents

Low-volume coagulation assay

Info

Publication number
SG11201500346QA
SG11201500346QA SG11201500346QA SG11201500346QA SG11201500346QA SG 11201500346Q A SG11201500346Q A SG 11201500346QA SG 11201500346Q A SG11201500346Q A SG 11201500346QA SG 11201500346Q A SG11201500346Q A SG 11201500346QA SG 11201500346Q A SG11201500346Q A SG 11201500346QA
Authority
SG
Singapore
Prior art keywords
low
coagulation assay
volume coagulation
volume
assay
Prior art date
Application number
SG11201500346QA
Inventor
Mark Dayel
Samartha Anekal
Paul Patel
Ian Gibbons
Elizabeth Holmes
Original Assignee
Theranos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theranos Inc filed Critical Theranos Inc
Publication of SG11201500346QA publication Critical patent/SG11201500346QA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84—Systems specially adapted for particular applications
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/4905—Determining clotting time of blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen
SG11201500346QA 2012-07-18 2013-07-18 Low-volume coagulation assay SG11201500346QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261673227P 2012-07-18 2012-07-18
PCT/US2013/051162 WO2014015191A2 (en) 2012-07-18 2013-07-18 Low-volume coagulation assay

Publications (1)

Publication Number Publication Date
SG11201500346QA true SG11201500346QA (en) 2015-02-27

Family

ID=49949383

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201500346QA SG11201500346QA (en) 2012-07-18 2013-07-18 Low-volume coagulation assay
SG10201603916UA SG10201603916UA (en) 2012-07-18 2013-07-18 Low-Volume Coagulation Assay

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201603916UA SG10201603916UA (en) 2012-07-18 2013-07-18 Low-Volume Coagulation Assay

Country Status (12)

Country Link
US (4) US9500639B2 (en)
EP (1) EP2875146B1 (en)
JP (4) JP2015528911A (en)
KR (1) KR102149318B1 (en)
CN (2) CN109884289B (en)
AU (1) AU2013292392A1 (en)
CA (2) CA2878875C (en)
HK (1) HK1210812A1 (en)
IL (1) IL236768B (en)
MX (1) MX360564B (en)
SG (2) SG11201500346QA (en)
WO (1) WO2014015191A2 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9500639B2 (en) 2012-07-18 2016-11-22 Theranos, Inc. Low-volume coagulation assay
MX2016002797A (en) 2013-09-06 2016-05-26 Theranos Inc Devices, systems, methods and kits for receiving a swab.
US10823743B1 (en) 2013-10-28 2020-11-03 Ifirst Medical Technologies, Inc. Methods of measuring coagulation of a biological sample
EP2975383A1 (en) * 2014-07-14 2016-01-20 Johann Wolfgang Goethe-Universität, Frankfurt am Main Method and device for analyzing a fluid medium such as a blood sample
FR3024237B1 (en) * 2014-07-25 2016-08-05 Stago Diagnostica METHOD OF DETERMINING THE STRUCTURAL PROFILE OF A FIBRIN FOOTBALL, REFLECTING ITS STABILITY, TO PREDICT THE RISK OF BLEEDING, THROMBOSIS OR RE-THROMBOSIS
WO2016049515A1 (en) 2014-09-26 2016-03-31 Abbott Point Of Care Inc. Microfabricated device with micro-environment sensors for assaying coagulation in fluid samples
EP3198270A1 (en) 2014-09-26 2017-08-02 Abbott Point Of Care, Inc. Cartridge device with fluidic junctions for coagulation assays in fluid samples
EP3198272B1 (en) 2014-09-26 2022-04-06 Abbott Point Of Care, Inc. Cartridge device identification for coagulation assays in fluid samples
WO2016049527A1 (en) 2014-09-26 2016-03-31 Abbott Point Of Care Inc. Cartridge device with segmented fluidics for assaying coagulation in fluid samples
WO2016049557A1 (en) * 2014-09-26 2016-03-31 Abbott Point Of Care Inc. Ellagic acid formulations for use in coagulation assays
US10114031B2 (en) 2014-09-26 2018-10-30 Abbott Point Of Care Inc. Single channel cartridge device for coagulation assays in fluid samples
US9903877B2 (en) 2014-09-26 2018-02-27 Abbott Point Of Care Inc. Sensors for assaying coagulation in fluid samples
AU2016286647B2 (en) * 2015-06-29 2019-11-07 Ca Casyso Gmbh Blood testing system and method
SG11201808475XA (en) 2016-04-15 2018-10-30 Baxalta Inc Method and apparatus for providing a pharmacokinetic drug dosing regiment
WO2018069582A1 (en) * 2016-10-14 2018-04-19 Commissariat à l'énergie atomique et aux énergies alternatives Method for characterising a sample comprising particles
US10896749B2 (en) 2017-01-27 2021-01-19 Shire Human Genetic Therapies, Inc. Drug monitoring tool
US10976305B2 (en) * 2017-04-27 2021-04-13 The University Of Chicago Coagulation testing in underfilled patient samples
CN108956542A (en) * 2017-05-18 2018-12-07 微采视像科技股份有限公司 The measuring method and its application apparatus of prothrombin time
US20210302412A1 (en) * 2018-07-25 2021-09-30 Ifirst Medical Technologies, Inc. Medical analyzer and diagnostic sample profiler
CN108982865B (en) * 2018-08-16 2021-05-11 上海原科实业发展有限公司 Thrombus elastography heparin quantitative detection kit and preparation method thereof
CN112654850A (en) * 2018-08-24 2021-04-13 深圳迈瑞生物医疗电子股份有限公司 Blood sample analyzer and blood sample mixing method
JP7135620B2 (en) * 2018-09-07 2022-09-13 ソニーグループ株式会社 Blood coagulation system analysis device, blood coagulation system analysis method, and blood coagulation system analysis program
CN109211729A (en) * 2018-10-29 2019-01-15 杨忠思 A kind of blood stagnation condition checkout gear and method for precisely medical treatment detection
CN114599973A (en) * 2019-10-17 2022-06-07 诺尔生物医药有限公司 Blood coagulation measuring device and method
WO2021140216A1 (en) * 2020-01-08 2021-07-15 Dsm Ip Assets B.V. Combination of clot-based fibrinogen test and enzyme-based fibrinogen test
CN113777332A (en) * 2020-06-09 2021-12-10 深圳迈瑞生物医疗电子股份有限公司 Immunoassay instrument and autoimmune analysis method
WO2021262706A1 (en) * 2020-06-23 2021-12-30 The Brigham And Women's Hospital, Inc. Single molecule assays for ultrasensitive detection of biomolecules
TWI819402B (en) 2020-12-22 2023-10-21 財團法人工業技術研究院 System and method for monitoring and controlling multi-phase condition of reactant in manufacturing process

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4121466A (en) * 1977-04-19 1978-10-24 Technicon Instruments Corporation Liquid dispenser with an improved probe
US5164598A (en) 1985-08-05 1992-11-17 Biotrack Capillary flow device
US5134229A (en) * 1990-01-12 1992-07-28 Johnson & Johnson Medical, Inc. Process for preparing a neutralized oxidized cellulose product and its method of use
US5840573A (en) * 1994-02-01 1998-11-24 Fields; Robert E. Molecular analyzer and method of use
PT764046E (en) * 1994-06-16 2000-12-29 Dade Behring Marburg Gmbh METHOD AND DEVICE FOR MIXING LIQUIDS
EP1004870A1 (en) * 1998-11-09 2000-05-31 Aurora Biosciences Corporation Liquid barriers for assays
US6582964B1 (en) 1999-05-12 2003-06-24 Cme Telemetrix Inc. Method and apparatus for rapid measurement of HbA1c
US7130046B2 (en) 2004-09-27 2006-10-31 Honeywell International Inc. Data frame selection for cytometer analysis
JP4384344B2 (en) * 2000-08-09 2009-12-16 拓之 今野 Blood coagulation time measurement method and apparatus using granular spot pattern by laser reflected light
US6432658B1 (en) 2000-09-13 2002-08-13 Affinity Biologicals, Inc. Method for measuring antithrombin activity
JP2002214241A (en) * 2000-11-20 2002-07-31 Minolta Co Ltd Microchip
US20030116447A1 (en) 2001-11-16 2003-06-26 Surridge Nigel A. Electrodes, methods, apparatuses comprising micro-electrode arrays
WO2004060172A1 (en) * 2002-12-31 2004-07-22 Marine Polymer Technologies, Inc. Hemostatic compositions and uses therefor
KR101330431B1 (en) 2003-09-11 2013-11-20 테라노스, 인코포레이티드 Medical device for analyte monitoring and drug delivery
WO2005049826A1 (en) 2003-11-22 2005-06-02 Ultizyme International Ltd. Method of detecting target molecule by using aptamer
US7399637B2 (en) * 2004-04-19 2008-07-15 Medtronic, Inc. Blood coagulation test cartridge, system, and method
EP1745145A4 (en) 2004-05-11 2008-03-26 Heptest Lab Inc Compositions, kit and one-step method for monitoring compounds having anti-factor xa and/or anti factor iia activities
ES2665788T3 (en) 2004-07-27 2018-04-27 Lsi Medience Corporation Procedure for automatic determination of a sample
US7544514B2 (en) * 2004-12-27 2009-06-09 David Varon Method and system for determining platelet-mediated clot formation
US8029783B2 (en) 2005-02-02 2011-10-04 Genentech, Inc. DR5 antibodies and articles of manufacture containing same
AU2006235025A1 (en) 2005-04-04 2006-10-19 The Regents Of The University Of California Inorganic materials for hemostatic modulation and therapeutic wound healing
WO2006119121A2 (en) * 2005-04-29 2006-11-09 University Of Louisville Research Foundation, Inc. Cell-surface decoration with active agents
WO2006121510A2 (en) 2005-05-09 2006-11-16 Theranos, Inc. Point-of-care fluidic systems and uses thereof
JP2008546542A (en) 2005-05-18 2008-12-25 プレジデント・アンド・フエローズ・オブ・ハーバード・カレツジ Production of conduction paths, microcircuits and microstructures in microfluidic networks
US20070073590A1 (en) 2005-08-22 2007-03-29 Cosentino Louis C Remote monitor for physiological parameters and durable medical supplies
US8741230B2 (en) 2006-03-24 2014-06-03 Theranos, Inc. Systems and methods of sample processing and fluid control in a fluidic system
US8012744B2 (en) 2006-10-13 2011-09-06 Theranos, Inc. Reducing optical interference in a fluidic device
JP4999613B2 (en) 2007-08-31 2012-08-15 シスメックス株式会社 Blood coagulation measurement reagent and blood coagulation time measurement method
SG188082A1 (en) * 2007-10-02 2013-03-28 Theranos Inc Modular point-of-care devices and uses thereof
US8372343B2 (en) 2007-12-07 2013-02-12 Sheldon Goldstein Multiple coagulation test cartridge and method of using same
KR20170138578A (en) 2008-03-26 2017-12-15 테라노스, 인코포레이티드 Methods and systems for assessing clinical outcomes
US20110104725A1 (en) * 2008-05-02 2011-05-05 Advanced Liquid Logic, Inc. Method of Effecting Coagulation in a Droplet
US8579117B2 (en) 2008-07-24 2013-11-12 The Trustees Of Princeton University Bump array device having asymmetric gaps for segregation of particles
EP2214011B1 (en) * 2008-08-01 2019-01-02 Sysmex Corporation Blood sample analyzing apparatus
JP5465850B2 (en) 2008-08-01 2014-04-09 シスメックス株式会社 Sample analysis system
EP2177624A1 (en) * 2008-10-02 2010-04-21 Siemens Healthcare Diagnostics Products GmbH Blood coagulation assays
US9157974B2 (en) * 2008-10-29 2015-10-13 T2 Biosystems, Inc. NMR detection of coagulation time
FR2943789B1 (en) 2009-03-26 2013-07-26 Commissariat Energie Atomique METHOD AND DEVICE FOR CHARACTERIZING THE DYNAMIC OF COAGULATION OR SEDIMENTATION OF A FLUID SUCH AS BLOOD OR BLOOD PLASMA
JP2010266236A (en) * 2009-05-12 2010-11-25 Sysmex Corp Device for analysis of sample
AU2010308329B2 (en) 2009-10-19 2016-10-13 Labrador Diagnostics Llc Integrated health data capture and analysis system
US20110166875A1 (en) * 2010-01-05 2011-07-07 Abbott Diabetes Care Inc. System and method for managing medical data and facilitating reimbursement for health care
TWI690594B (en) 2011-01-21 2020-04-11 美商賽瑞諾斯Ｉｐ有限責任公司 Systems and methods for sample use maximization
US8697449B2 (en) * 2011-04-01 2014-04-15 Spectral Sciences, Inc. Optical blood coagulation monitor and method
US8435738B2 (en) 2011-09-25 2013-05-07 Theranos, Inc. Systems and methods for multi-analysis
US9500639B2 (en) 2012-07-18 2016-11-22 Theranos, Inc. Low-volume coagulation assay

Also Published As

Publication number Publication date
IL236768A0 (en) 2015-03-31
JP2022116194A (en) 2022-08-09
CN109884289B (en) 2022-07-26
US20220137075A1 (en) 2022-05-05
JP2015528911A (en) 2015-10-01
CN104662163A (en) 2015-05-27
CA3124500A1 (en) 2014-01-23
US20170023594A1 (en) 2017-01-26
IL236768B (en) 2019-10-31
EP2875146A4 (en) 2016-03-02
AU2013292392A1 (en) 2015-01-29
KR102149318B1 (en) 2020-10-14
US20140087403A1 (en) 2014-03-27
WO2014015191A3 (en) 2014-05-08
EP2875146A2 (en) 2015-05-27
US9500639B2 (en) 2016-11-22
WO2014015191A2 (en) 2014-01-23
CA2878875C (en) 2021-09-07
MX2015000808A (en) 2015-05-07
CA2878875A1 (en) 2014-01-23
BR112015001048A8 (en) 2021-07-06
JP2021009153A (en) 2021-01-28
SG10201603916UA (en) 2016-07-28
JP2019002939A (en) 2019-01-10
MX360564B (en) 2018-11-07
HK1210812A1 (en) 2016-05-06
US20150301018A1 (en) 2015-10-22
CN109884289A (en) 2019-06-14
BR112015001048A2 (en) 2017-06-27
US11119110B2 (en) 2021-09-14
KR20150034793A (en) 2015-04-03
EP2875146B1 (en) 2022-05-18

Similar Documents

Publication Publication Date Title
HK1210812A1 (en) Low-volume coagulation assay
HK1213019A1 (en) Improved assay methods
HRP20171401T1 (en) Disposable circumcising anastomat
GB201310691D0 (en) Assay
EP2932696A4 (en) Assay apparatus
EP2890427A4 (en) Electrochemically-actuated microfluidic devices
GB201304810D0 (en) Assay
GB201215571D0 (en) Assay method
IL239408A0 (en) Truss configuration
GB201203938D0 (en) Assay system
EP2981823A4 (en) Novel Assay
PL2626134T3 (en) Pipette
GB201212528D0 (en) Assay
GB201209664D0 (en) Assay device
EP2844770A4 (en) Mrm-ms signature assay
GB201216122D0 (en) Screening assay
GB201315011D0 (en) Assay
GB201221011D0 (en) Assay method
GB201219024D0 (en) Assay
GB201213229D0 (en) Assay
GB201212778D0 (en) Assay
AP00418S1 (en) Assay devices
GB201314951D0 (en) Assay
GB201312918D0 (en) Assay
GB201309760D0 (en) Assay